Business
Avanos Medical, Inc. Announces First Quarter 2025 Results
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results.
About this update from Avanos Medical, Inc.
[{"type":"text","content":"ALPHARETTA, Ga., May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results.","length":131,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Avanos Medical Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Avanos Medical Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":65,"url":"https://media.zenfs.com/en/prnewswire.com/a3171dfd9d9d08106baabe2b965e0542"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KRp2NVXwfDM6PDPsfmGn4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTExNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/a3171dfd9d9d08106baabe2b965e0542","width":400,"height":65}},"href":"https://mma.prnewswire.com/media/713850/Avanos_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""In my first couple of weeks at Avanos, I've noticed that the transformation efforts made around the portfolio, the organizational structure and cost management have positioned us well to accelerate our growth profile," said David Pacitti, Avanos's recently appointed Chief Executive Officer. Pacitti continued, "I really like the energy and strategic focus we have right now, which can be leveraged for more consistent execution, to identify more go-to-market strategies and continued margin profile enhancements."","length":543,"tagName":"p"},{"type":"text","content":"First Quarter 2025 Financial Highlights","length":39,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Total net sales were $167.5 million, a 0.8% increase from the comparable prior year period.","length":91,"tagName":"p"}]},{"val":[{"type":"text","content":"Net income was $6.6 million, compared to net income from continuing operations of $0.5 million a year ago.","length":106,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted net income was $12.0 million, compared to $10.1 million a year ago.","length":76,"tagName":"p"}]},{"val":[{"type":"text","content":"Diluted earnings per share was $0.14, compared to $0.01 a year ago.","length":67,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted diluted earnings per share was $0.26, compared to $0.22 a year ago.","length":76,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA was $21.6 million, compared to $21.6 million a year ago.","len...